
|Videos|March 3, 2023
A Medical Oncologist’s Recommended Interventions For CV Risk Mitigation
Urologist David Morris, MD, FACS, shares his perspective on communicating cardiovascular risk to patients starting androgen deprivation therapy.
Advertisement
Episodes in this series

January 2023 AbbVie Inc. Company Confidential
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Jason Hafron, MD, recaps prostate cancer data from ESMO 2025
2
Radioligands and ADT alternatives emerge in prostate cancer treatment
3
Beyond PSA: Jonathan Henderson, MD, on precision tools for prostate cancer
4
ORIC-944 shows promise in combination with ARPIs for mCRPC
5
























